XEN1101, a novel, potent potassium channel modulator: Interim data from an ongoing, long-term, open-label extension of a Phase 2b study (X-TOLE) in adults with focal onset seizures (FOS)

被引：0
|
作者：
French, J. [1 ,2 ]
Porter, R. [3 ]
Perucca, E. [4 ,5 ]
Brodie, M. [6 ]
Rogawski, M. A. [7 ]
Harden, C. [8 ]
Qian, J. [8 ]
Rosenblut, C. Luzon [8 ]
Kenney, C. [8 ]
Beatch, G. N. [8 ]
机构：
[1] NYU, Grossman Sch Med, New York, NY USA
[2] NYU, NYU Langone Hlth, New York, NY USA
[3] Univ Penn, Philadelphia, PA USA
[4] Monash Univ, Melbourne, Vic, Australia
[5] Univ Melbourne, Austin Hlth, Heidelberg, Australia
[6] Univ Glasgow, Dept Med & Therapeut, Western Infirm, Glasgow, Scotland
[7] Univ Calif Davis, Sch Med, Sacramento, CA USA
[8] Xenon Pharmaceut Inc, Vancouver, BC, Canada
来源：
EPILEPSIA | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
631
引用
收藏
页码：184 / 184
页数：1
相关论文
共 29 条
  • [1] XEN1101, a novel potassium channel modulator: interim data from an ongoing, long-term, open-label extension of a phase 2b study (X-TOLE) in adults with focal epilepsy
    French, J.
    Porter, R.
    Perucca, E.
    Brodie, M.
    Rogawski, M. A.
    Harden, C.
    Qian, J.
    Luzon-Rosenblut, C.
    Kenney, C.
    Beatch, G. N.
    EPILEPSIA, 2023, 64 : 275 - 276
  • [2] XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2b study (X-TOLE) in Adults with Focal Epilepsy
    French, Jacqueline
    Porter, Roger
    Perucca, Emilio
    Brodie, Martin
    Rogawski, Michael
    Harden, Cynthia
    Qian, Jenny
    Luzon-Rosenblut, Constanza
    Kenney, Christopher
    Beatch, Gregory
    NEUROLOGY, 2023, 100 (17)
  • [3] Quality- of- life improvements in adults with focal onset seizures treated with XEN1101 in an ongoing, long-term, open-label extension of a phase 2b study (X-TOLE)
    Brandt, C.
    Villanueva, V.
    Harden, C.
    Qian, J.
    Luzon-Rosenblut, C.
    Wagner, J.
    Kenney, C.
    Beatch, G. N.
    EPILEPSIA, 2023, 64 : 276 - 276
  • [4] Phase 2b Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal onset seizures (X-TOLE)
    French, J.
    Porter, R.
    Perucca, E.
    Brodie, M.
    Rogawski, M.
    Pimstone, S.
    Aycardi, E.
    Harden, C.
    Xu, Y.
    Rosenblut, C. Luzon
    Kenney, C.
    Beatch, G.
    EPILEPSIA, 2022, 63 : 117 - 118
  • [5] Phase 2B Efficacy and Safety of XEN1101, a Novel Potassium Channel Modulator, In Adults with Focal Epilepsy (X-TOLE)
    French, Jacqueline
    Porter, Roger
    Perucca, Emilio
    Brodie, Martin
    Rogawski, Michael A.
    Pimstone, Simon
    Aycardi, Ernesto
    Harden, Cynthia
    Xu, Yi
    Rosenblut, Constanza Luzon
    Kenney, Christopher
    Beatch, Greg
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1427 - 1427
  • [6] Rapid onset of efficacy of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: Results from a phase 2b study (X-TOLE)
    Kenney, C.
    French, J.
    Porter, R.
    Perucca, E.
    Brodie, M.
    Rogawski, M.
    Harden, C.
    Rosenblut, C. Luzon
    Qian, J.
    Leung, J.
    Beatch, G.
    EPILEPSIA, 2022, 63 : 136 - 136
  • [7] The Impact of Disease Severity on Efficacy from a Phase 2b Study of XEN1101, A Novel Potassium Channel Opener, in Adults With Focal Epilepsy (X-TOLE)
    Kenney, Christopher
    French, Jacqueline
    Porter, Roger
    Perucca, Emilio
    Brodie, Martin
    Rogawski, Michael A.
    Harden, Cynthia
    Qian, Jenny
    Beatch, Greg
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1427 - 1428
  • [8] The impact of disease severity on efficacy from a Phase 2b study of XEN1101, a novel potassium channel opener, in adults with focal epilepsy (X-TOLE)
    Kenney, C.
    French, J.
    Porter, R.
    Perucca, E.
    Brodie, M.
    Rogawski, M.
    Harden, C.
    Rosenblut, C. Luzon
    Qian, J.
    Leung, J.
    Beatch, G.
    EPILEPSIA, 2022, 63 : 136 - 136
  • [9] Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy
    French, Jacqueline A.
    Porter, Roger J.
    Perucca, Emilio
    Brodie, Martin J.
    Rogawski, Michael A.
    Harden, Cynthia
    Qian, Jenny
    Rosenblut, Constanza Luzon
    Kenney, Christopher
    Beatch, Gregory N.
    X-TOLE Study Grp
    EPILEPSIA OPEN, 2025,
  • [10] Long-term, quality of life in epilepsy inventory-31 (QOLIE-31) improvements in adults with focal onset seizures treated with XEN1101 in an ongoing, open-
    Brandt, C.
    Villanueva, V.
    Harden, C.
    Qian, J.
    Rosenblut, C. Luzon
    Wagner, J.
    Kenney, C.
    Beatch, G. N.
    EPILEPSIA, 2024, 65 : 183 - 184
123